Select Committee · Health and Social Care Committee

Pharmacy

Status: Closed Opened: 8 Jun 2023 Closed: 30 May 2024 20 recommendations 10 conclusions 1 report

The pharmacy inquiry will explore issues impacting different types of pharmacy, with a particular focus on community, primary care and hospital pharmacy services. During a time of change and reorganisation across the health and care system, and following upheaval driven by the Covid-19 pandemic, the inquiry will assess the current status of pharmacy in England …

Clear

Reports

1 report
Title HC No. Published Items Response
Third Report - Pharmacy HC 140 29 May 2024 30 Responded

Recommendations & Conclusions

11 items
2 Recommendation Third Report - Pharmacy Deferred

Overhaul the Community Pharmacy Contractual Framework to address funding gaps and reduce complexity.

We recommend that the Community Pharmacy Contractual Framework (CPCF) is completely overhauled, in close consultation with the community pharmacy sector. Any new framework must: a) close the gap in funding that community pharmacy has experienced over the course of the current CPCF; b) focus on reducing complexity and ensure pharmacy …

Government response. The government's response focused on Serious Shortage Protocols (SSPs) as a tool to manage medicine shortages, explaining their use and stating that the policy will continue to be kept under review. It did not address the recommendation to completely overhaul …
Department of Health and Social Care
5 Recommendation Third Report - Pharmacy Deferred

Review the effectiveness of Serious Shortage Protocols, focusing on timing and administrative burden.

We recommend that the Government reviews the effectiveness of Serious Shortage Protocols, with a focus on their timing and their administrative burden. (Paragraph 49) 44 Pharmacy

Government response. The government discusses the role of National Patient Safety Alerts and Medicine Supply Notifications in managing shortages, but does not address the specific recommendation to review the effectiveness, timing, or administrative burden of Serious Shortage Protocols (SSPs).
Department of Health and Social Care
7 Recommendation Third Report - Pharmacy Deferred

Introduce generic substitution following consultation to ensure patient safety and supply chain stability.

We believe that allowing generic substitution would be an important way of reducing the need for patients to return to their GP for out-of-stock medication. We further recommend the introduction of generic substitution, which should follow a government consultation focusing on how best this policy could be implemented to ensure …

Government response. The government responds by outlining its commitment to expanding the role of pharmacists and introducing prescribing services, but does not address the specific recommendation to introduce generic substitution or to consult on its implementation.
Department of Health and Social Care
8 Recommendation Third Report - Pharmacy Deferred

Set out impact of Patient Safety Alerts on private prescribing and enforcement measures.

In their response to this report, the Government should set out what impact it believes National Patient Safety Alerts have on private prescribing and what scrutiny and enforcement measures are in place to ensure private prescribers adhere to these alerts.

Government response. The government acknowledges the point but then discusses the new HIV Action Plan for 2025-30 and PrEP access, mentioning pilot studies for PrEP delivery, without addressing the impact of National Patient Safety Alerts on private prescribing or their enforcement.
Department of Health and Social Care
9 Conclusion Third Report - Pharmacy Deferred

Require the Government to communicate its understanding of global medicines supply chain risks.

The global supply chain for medicines is complex, with a range of different actors involved in getting medicines from the raw materials to the manufacturer to the patient. The Government needs a clearer understanding and overview of the whole process, and the risks at each stage. If the Government already …

Government response. The government discusses its commitment to expanding pharmacy services and promoting the Pharmacy First service, but does not address the recommendation about gaining a clearer understanding of the entire medicines supply chain and communicating it to Parliament.
Department of Health and Social Care
10 Recommendation Third Report - Pharmacy Deferred

Commission an independent review of the medicines supply chain, including resilience and generic availability.

The Government should commission an independent review of the medicines supply chain. Given the impact that shortages are having, this should be commissioned as soon as possible and completed within 6 months of starting. The review should assess, and suggest ways of improving, the resilience of the supply chain, the …

Government response. The government discusses past and present pharmacy funding mechanisms, including the phased-out establishment payment and the Pharmacy First monthly payment, without addressing the recommendation to commission an independent review of the medicines supply chain.
Department of Health and Social Care
11 Conclusion Third Report - Pharmacy Deferred

Pharmacy's potential to improve healthcare access requires substantial public funding and support.

We have been encouraged to hear the enthusiasm within the pharmacy profession to deliver more patient facing care. However, the undoubted potential for pharmacy to improve access to health care, crucially including immunisations, and reduce pressure on general practice and other areas of the health system can only be realised …

Government response. The government details the charging structure for Pharmacy First consultations and prescription medications, and references a 2018 report on over-the-counter medication, instead of addressing the need for increased public funding and support for expanded pharmacy services.
Department of Health and Social Care
15 Recommendation Third Report - Pharmacy Deferred

Caution against mandating widespread implementation of hub and spoke systems in pharmacies.

While hub and spoke arrangements may be beneficial to some pharmacies, we do not believe this is a ‘silver bullet’ in terms of efficiencies. We urge the Government not to assume that hub and spoke alone will deliver the extra capacity pharmacists clearly need to deliver clinical services. We note …

Government response. The government deflected the recommendation about hub and spoke arrangements by discussing the eligibility of MPharm students for the Learning Support Fund and exploring consistent policy for funding their travel and accommodation costs.
Department of Health and Social Care
16 Conclusion Third Report - Pharmacy Deferred

Medicine shortages reinforce public concerns about GP referrals from community pharmacies.

Public concerns about being referred back to the GP if they use community pharmacy to access healthcare should ring alarm bells for the Government. It is encouraging that this does not seem to be the experience within Pharmacy First, but we know that medicine shortages are driving people back to …

Government response. The government stated that funding for the Additional Role Reimbursement Scheme (ARRS) is under review as part of the 2025/26 GP contract arrangements, with final details to be published after the consultation concludes, rather than directly addressing public concerns about …
Department of Health and Social Care
18 Conclusion Third Report - Pharmacy Deferred

Support for smaller pharmacies is needed to provide private clinical consultation spaces.

Community pharmacies offering clinical services must have private, comfortable spaces in which to see patients. We acknowledge the minister’s comments around pharmacies being private businesses, but they are ultimately expected to provide NHS services. As the expanding availability of clinical services in pharmacy settings is encouraged, we believe a more …

Government response. The government deflected the recommendation regarding private consultation spaces by focusing on the refreshed Long Term Workforce Plan and workforce development, including supporting pharmacists to become independent prescribers and piloting an Independent Prescriber Pathfinder Programme.
Department of Health and Social Care
19 Recommendation Third Report - Pharmacy Deferred

Create new Establishment Payment for community pharmacies to develop patient consultation spaces.

We recommend the creation of a new “Establishment Payment” to be paid to eligible community pharmacies to support the development of consultation spaces for patients. This funding should be targeted at pharmacies that are the most reliant on NHS work as their main source of income and could be linked …

Government response. The government deflected the recommendation for a new 'Establishment Payment' to support consultation spaces by discussing pharmacy workforce integration within Integrated Care Boards and the ongoing exploration of how to best utilise pharmacy skills for future services.
Department of Health and Social Care

Oral evidence sessions

4 sessions
Date Witnesses
26 Mar 2024 David Webb · NHS England, Dr Amanda Doyle OBE · NHS England, Rt Hon Dame Andrea Leadsom MP · Department of Health and Social Care View ↗
19 Feb 2024 Dr Rick Greville · The Association of the British Pharmaceutical Industry (ABPI), Helen Kirrane · Diabetes UK, Janet Morrison · Community Pharmacy England, Mark Samuels · British Generic Manufacturers Association (BGMA), Mike Dent · Community Pharmacy England View ↗
16 Jan 2024 Deborah Evans · Remedi Health, Duncan Rudkin · General Pharmaceutical Council, Mark Koziol · The Pharmacists' Defence Association, Nicola Stockmann · Association of Pharmacy Technicians UK, William Pett · Healthwatch England View ↗
21 Nov 2023 Dr Graham Stretch · Primary Care Pharmacy Association, Dr James Davies · Royal Pharmaceutical Society, Dr Leyla Hannbeck · Association of Independent Multiple Pharmacies, Jay Badenhorst · National Pharmacy Association, Malcolm Harrison · Company Chemists' Association View ↗